MIDOL LIQUID GELS Drug Patent Profile
✉ Email this page to a colleague
When do Midol Liquid Gels patents expire, and what generic alternatives are available?
Midol Liquid Gels is a drug marketed by Bionpharma and is included in one NDA.
The generic ingredient in MIDOL LIQUID GELS is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and forty suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Midol Liquid Gels
A generic version of MIDOL LIQUID GELS was approved as ibuprofen by STRIDES PHARMA on September 24th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MIDOL LIQUID GELS?
- What are the global sales for MIDOL LIQUID GELS?
- What is Average Wholesale Price for MIDOL LIQUID GELS?
Summary for MIDOL LIQUID GELS
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 202 |
Clinical Trials: | 1,537 |
DailyMed Link: | MIDOL LIQUID GELS at DailyMed |
Recent Clinical Trials for MIDOL LIQUID GELS
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Jerry Vockley, MD, PhD | Phase 2 |
Ultragenyx Pharmaceutical Inc | Phase 2 |
University of California, San Francisco | Phase 4 |
US Patents and Regulatory Information for MIDOL LIQUID GELS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Bionpharma | MIDOL LIQUID GELS | ibuprofen | CAPSULE;ORAL | 021472-001 | Oct 18, 2002 | OTC | Yes | Yes | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MIDOL LIQUID GELS
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bionpharma | MIDOL LIQUID GELS | ibuprofen | CAPSULE;ORAL | 021472-001 | Oct 18, 2002 | 6,251,426 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
EU/EMA Drug Approvals for MIDOL LIQUID GELS
Company | Drugname | Inn | Product Number / Indication | Status | Generic | Biosimilar | Orphan | Marketing Authorisation | Marketing Refusal |
---|---|---|---|---|---|---|---|---|---|
Recordati Rare Diseases | Pedea | ibuprofen | EMEA/H/C/000549 Treatment of a haemodynamically significant patent ductus arteriosus in preterm newborn infants less than 34 weeks of gestational age. |
Authorised | no | no | no | 2004-07-28 | |
>Company | >Drugname | >Inn | >Product Number / Indication | >Status | >Generic | >Biosimilar | >Orphan | >Marketing Authorisation | >Marketing Refusal |
International Patents for MIDOL LIQUID GELS
See the table below for patents covering MIDOL LIQUID GELS around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Canada | 2382292 | GELS MOUS CONTENANT DE L'IBUPROFENE (IBUPROFEN-CONTAINING SOFTGELS) | ⤷ Subscribe |
Austria | 357229 | ⤷ Subscribe | |
World Intellectual Property Organization (WIPO) | 0115688 | ⤷ Subscribe | |
Australia | 780212 | ⤷ Subscribe | |
Germany | 60034044 | ⤷ Subscribe | |
Poland | 362850 | ⤷ Subscribe | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for MIDOL LIQUID GELS
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1781277 | PA2024501 | Lithuania | ⤷ Subscribe | PRODUCT NAME: IBUPROFENO IR PARACETAMOLIO DERINYS; REGISTRATION NO/DATE: LT/1/23/5212/001-002 20230726 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
MIDOL LIQUID GELS Market Analysis and Financial Projection Experimental
More… ↓